Plasticell Signs Deal With JCR Pharmaceuticals To Use Combicult...

Plasticell, the biotechnology company specializing in stem cell differentiation, has today announced that it has signed a collaboration agreement with JCR Pharmaceuticals Co., Ltd. of Ashiya, Hyogo Pref., Japan, to discover custom stem cell culture media using its award-winning combinatorial stem cell technology, CombiCultA .

http://ift.tt/1fy4t5n